MacuLogix introduces next generation of AMD testing device

January 28, 2020
MacuLogix Inc. announced its next generation of dark adaptation functional testing with AdaptDx Pro guided by Theia to detect age-related macular…

Meeting NewsVideo

VIDEO: AI-guided image analysis drives progress in ophthalmology

January 28, 2020
TREVISO, Italy — Why are reading centers, images and image analysis so important in ophthalmology? At the Retina 2020: New Trends meeting…

Exonate announces collaboration to develop retinal disease treatment

January 28, 2020
Exonate announced a collaboration with Janssen Pharmaceuticals to develop new eye drops to treat retinal vascular diseases. This program may improve…

Meeting News

Zimura shows promise in treatment of geographic atrophy in AMD

January 27, 2020
Complement C5 is a viable target for inhibition to potentially prevent or slow retinal pigment epithelial cell death in patients with geographic…

Ocuphire licenses oral drug candidate for retinal diseases

January 27, 2020
Ocuphire Pharma entered into an agreement with Apexian Pharmaceuticals for a worldwide sublicense for Apexian’s Ref-1 inhibitor program…

Editas reports advances in CRISPR development

January 23, 2020
Editas Medicine is on track to “make history” with the enrollment of its in vivo CRISPR genome-editing technology clinical trial, CEO…

Meeting News

Step therapy an onerous process for providing patient care

January 20, 2020
KOLOA, Hawaii — Step therapy, an insurance protocol requiring patients to try and fail certain drugs before allowing access to other therapies…

Meeting News

Adverum reports significant progress with intravitreal gene therapy program

January 17, 2020
Adverum Biotechnologies has made significant progress in its lead clinical program for intravitreal gene therapy for retinal diseases, Leone

Phase 3 trial to investigate Port Delivery System in DME

January 17, 2020
Genentech and Roche initiated a phase 3 clinical trial to investigate the Port Delivery System with ranibizumab to treat patients with diabetic…

Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more…

First US patient implanted with wireless retinal device

January 16, 2020
A surgeon at the UPMC Eye Center has implanted the first patient in the United States with a wireless retinal device to restore partial sight to…

In the Journals

Ocular changes differ in ground-based analogue of weightlessness

January 15, 2020
Subjects who underwent a ground-based analogue of weightlessness experienced greater peripapillary total retinal thickness but less choroidal…

Iveric plans design of new Zimura trial

January 14, 2020
Iveric bio announced the design of a second pivotal trial for Zimura, a complement C5 inhibitor in development for the treatment of geographic…

Steroid administration to change in next cohorts of Adverum’s OPTIC trial

January 13, 2020
Adverum Biotechnologies will change how patients receive steroids to manage inflammation in the third and fourth cohorts of its phase 1 OPTIC trial…

In the JournalsPerspective

Ranibizumab treat-and-extend as effective as monthly injections in wet AMD

January 10, 2020
The CANTREAT trial found a treat-and-extend strategy with ranibizumab for patients with neovascular age-related macular degeneration was not worse…

AGTC’s retinitis pigmentosa gene therapy candidate shows positive 6-month results

January 10, 2020
An adeno-associated virus-based gene therapy improved visual function in patients with X-linked retinitis pigmentosa 6 months after dosing, Applied…


CPT codes available for Notal Vision’s home OCT system

January 9, 2020
Three new Category III codes have been established for Notal Vision’s home OCT system by the American Medical Association’s CPT Editorial…

Oxurion’s DME therapy shows positive phase 1 results

January 7, 2020
THR-687, a diabetic macular edema treatment candidate, was shown to be safe and well tolerated in a phase 1 trial, Oxurion announced in a press…

In the Journals

CPAP therapy may lower risk of diabetic retinopathy

January 7, 2020
Researchers found that the prevalence of diabetic retinopathy was lower in patients with sleep apnea who were compliant with continuous positive…

Meeting NewsVideo

VIDEO: Retinal ganglion cells preserved in LHON

January 6, 2020
NEPTUNE, N.J. – All retinal ganglion cells are equally damaged in most retinal neuropathies, but a case presented here at the New Jersey…